Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial

Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial

ABSTRACT: Background: In the Preterm Erythropoietin (Epo) NeUroproTection (PENUT) Trial, potential biomarkers of neurological injury were measured to determine their association with outcomes at two years of age and whether Epo treatment decreased markers of inflammation in extremely preterm (<2...

Full description

Bibliographic Details
Main Authors: Thomas R. Wood, Pratik Parikh, Bryan A. Comstock, Janessa B. Law, Theo K. Bammler, Karl C. Kuban, Dennis E. Mayock, Patrick J. Heagerty, Sandra Juul, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:EBioMedicine
Subjects:
Premature
Inflammation
Neurodevelopment
Biomarker
Erythropoietin
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421003984

Internet

http://www.sciencedirect.com/science/article/pii/S2352396421003984

Similar Items